Anti-adhesion decreases negative tissue changes in a murine model of vasectomy
Editorial

Anti-adhesion decreases negative tissue changes in a murine model of vasectomy

Parviz K. Kavoussi^

Austin Fertility & Reproductive Medicine/Westlake IVF, Austin, TX, USA

^ORCID: 0000-0001-7390-5837.

Correspondence to: Parviz K. Kavoussi. 300 Beardsley Lane, Bldg B, Suite 200, Austin, TX 78746, USA. Email: pkavoussi@hotmail.com.

Comment on: Chung JH, Chung Y, Cha YJ, et al. Anti-adhesion agent to prevent of post-operative adhesion and fibrosis after vasectomy: a study using a rat model. Transl Androl Urol 2022;11:1234-44.


Submitted Oct 01, 2022. Accepted for publication Nov 03, 2022.

doi: 10.21037/tau-22-647


Chung and colleagues demonstrated that the use of an anti-adhesive agent at the time of vasectomy in a murine experimental model can significantly decrease the extent of post-operative adhesions, fibrosis, and inflammation with improved preservation of muscle structure (1). The authors extrapolate that this improvement in tissue properties may decrease the risk of post-vasectomy pain syndrome (PVPS). Although the authors list histologic findings of PVPS to include thickened basement membrane, degeneration of the spermatic cord, perineural fibrosis, and adhesions (2); it would have also been interesting to have assessed if Wallerian degeneration of the trifecta nerve complex was also demonstrated in higher degrees in tissue of the animals not treated with the anti-adhesive agent. The authors note this as a limitation. Wallerian degeneration has been demonstrated to be prevalent histopathologically in men with clinical PVPS (3). Another distinction that should be considered is that there is a subgroup of men with PVPS who are thought to suffer due to epididymal congestion which presents with a significantly dilated, boggy, epididymis with point tenderness on examination. Although in congestive cases, there is interstitial fibrosis (4), the question arises if men in this category would benefit from the anti-adhesive agent as it seems these men develop pain syndrome due the obstructive effect on the epididymis more than the tissue changes around the site of vasectomy.

As stated by the authors, PVPS is typically a late complication of vasectomy so it may also be useful to assess these comparative tissue changes after a longer duration from vasectomy, perhaps at a 3-month interval rather than at a 2-week interval pos-operatively. As far as experimental design, it may also have been useful to use the anti-adhesive agent adjacent on one vas and not on the other in the same animals to exclude inter-individual animal variability. The authors note this as limitation but that it is a challenge due to Sprague-Dawley rat anatomy. In future study it may also be interesting to see if there is a difference in tissue reaction if metal clips are applied to the vasa as many clinicians use this technique which may result in even more inflammatory tissue responses. Ultimately, this is an elegantly performed pre-clinical animal study demonstrating a tissue benefit of using an anti-adhesive agent in an animal model. A randomized clinical trial, although challenging to power considering the incidence of PVPS, would benefit in the understand of the utility of anti-adhesive agent use at the time of vasectomy clinically and if the reduction of adverse tissue changes demonstrated in this study translate to reduction in clinical PVPS.


Acknowledgments

Funding: None.


Footnote

Provenance and Peer Review: This article was commissioned by the editorial office, Translational Andrology and Urology. The article did not undergo external peer review.

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-22-647/coif). PK receives honoraria from the speaker bureaus of Halozyme Therapeutics, Acerus Pharmaceuticals, and Clarus Therapeutics, all not related to this work. The author has no other conflicts of interest to declare.

Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Chung JH, Chung Y, Cha YJ, et al. Anti-adhesion agent to prevent of post-operative adhesion and fibrosis after vasectomy: a study using a rat model. Transl Androl Urol 2022;11:1234-44. [Crossref] [PubMed]
  2. Tan WP, Levine LA. An overview of the management of post-vasectomy pain syndrome. Asian J Androl 2016;18:332-7. [Crossref] [PubMed]
  3. Parekattil SJ, Gudeloglu A, Brahmbhatt JV, et al. Trifecta nerve complex: potential anatomical basis for microsurgical denervation of the spermatic cord for chronic orchialgia. J Urol 2013;190:265-70. [Crossref] [PubMed]
  4. Tandon S, Sabanegh E Jr. Chronic pain after vasectomy: a diagnostic and treatment dilemma. BJU Int 2008;102:166-9. [Crossref] [PubMed]
Cite this article as: Kavoussi PK. Anti-adhesion decreases negative tissue changes in a murine model of vasectomy. Transl Androl Urol 2022;11(11):1473-1474. doi: 10.21037/tau-22-647

Download Citation